Correct answer = A. Hypertension.
Since flecainide can increase the risk of sudden cardiac death in those with a history of structural heart disease, only A (Hypertension) will allow for flecainide initiation. Structural heart disease includes left ventricular hypertrophy, heart failure, and atherosclerotic heart disease.